Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, and COVID-19 Clinical Research Studies.
Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults
SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
Recommendations for respiratory syncytial virus surveillance at the national level
SARS-CoV-2 viral dynamics in non-human primates
Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
Monitoring approaches for health-care workers during the COVID-19 pandemic
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020
Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care
Oseltamivir Resistance in Severe Influenza A(H1N1)pdm09 Pneumonia and Acute Respiratory Distress Syndrome: A French Multicenter Observational Cohort Study
Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014
Influenza B burden during seasonal influenza epidemics in France
Clinical Characteristics Are Similar across Type A and B Influenza Virus Infections
Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003–2013
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013
Open source clinical science for emerging infections
Oseltamivir–zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections